IsoPlexis Corp financial data

Industry
Laboratory Analytical Instruments
Location
35 Ne Industrial Road, Branford, CT
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-K - Q4 2022 - Mar 2, 2023

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 730 %
Quick Ratio 239 %
Debt-to-equity 79 %
Return On Equity -132 % -148%
Return On Assets -74 %
Operating Margin -604 % -36.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 39.8M shares +1.86%
Common Stock, Shares, Outstanding 39.7M shares +1.63%
Entity Public Float 13.2M USD
Common Stock, Value, Issued 40K USD +2.56%
Weighted Average Number of Shares Outstanding, Basic 39.3M shares +284%
Weighted Average Number of Shares Outstanding, Diluted 39.3M shares +284%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 16.8M USD -2.88%
Research and Development Expense 23.5M USD +12.1%
Selling and Marketing Expense 29.9M USD -20.9%
General and Administrative Expense 42.7M USD +62%
Operating Income (Loss) -101M USD -32.6%
Net Income (Loss) Attributable to Parent -106M USD -29.9%
Earnings Per Share, Basic -2.7 USD/shares +70%
Earnings Per Share, Diluted -2.7 USD/shares +70%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 37.5M USD -70.4%
Accounts Receivable, after Allowance for Credit Loss, Current 4.5M USD +9.81%
Inventory, Net 27.5M USD +13.2%
Assets, Current 71.9M USD -54.6%
Property, Plant and Equipment, Net 11.2M USD +94.5%
Operating Lease, Right-of-Use Asset 5.07M USD
Other Assets, Noncurrent 1.07M USD -52.1%
Assets 109M USD -41.8%
Accounts Payable, Current 2.78M USD -42.5%
Employee-related Liabilities, Current 2.59M USD -29.3%
Accrued Liabilities, Current 13.5M USD +72.4%
Contract with Customer, Liability, Current 1.43M USD +56.7%
Liabilities, Current 17.7M USD +30.4%
Operating Lease, Liability, Noncurrent 3.74M USD
Liabilities 67.8M USD +49.9%
Accumulated Other Comprehensive Income (Loss), Net of Tax -6K USD
Retained Earnings (Accumulated Deficit) -240M USD -79.1%
Stockholders' Equity Attributable to Parent 41.3M USD -71%
Liabilities and Equity 109M USD -41.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -31.9M USD -121%
Net Cash Provided by (Used in) Financing Activities 7.5M USD -25%
Net Cash Provided by (Used in) Investing Activities -4.55M USD -452%
Common Stock, Shares Authorized 400M shares 0%
Common Stock, Shares, Issued 39.7M shares +1.63%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 37.5M USD -70.4%
Interest Paid, Excluding Capitalized Interest, Operating Activities 987K USD +37.3%
Deferred Tax Assets, Valuation Allowance 61.2M USD +84.3%
Deferred Tax Assets, Gross 62.6M USD +87.7%
Operating Lease, Liability 5.32M USD
Depreciation 1.9M USD +58.3%
Payments to Acquire Property, Plant, and Equipment 4.39M USD +495%
Lessee, Operating Lease, Liability, to be Paid 5.77M USD
Property, Plant and Equipment, Gross 16.2M USD +83.6%
Operating Lease, Liability, Current 1.59M USD
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.77M USD
Lessee, Operating Lease, Liability, to be Paid, Year One 1.81M USD
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 446K USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.41M USD
Deferred Tax Assets, Operating Loss Carryforwards 48.3M USD +58%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 20M shares
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 776K USD
Operating Lease, Payments 418K USD
Additional Paid in Capital 281M USD +1.82%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 980K USD +218%
Deferred Tax Assets, Net of Valuation Allowance 1.35M USD +1077%
Share-based Payment Arrangement, Expense 877K USD +823%
Interest Expense 1.49M USD +39.4%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%